
TY  - JOUR
TI  - Poster Abstracts
JO  - Immunology
VL  - 135
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/j.1365-2567.2011.03534.x
DO  - doi:10.1111/j.1365-2567.2011.03534.x
SP  - 52
EP  - 212
PY  - 2011
ER  - 

TY  - JOUR
TI  - Posters
JO  - Basic & Clinical Pharmacology & Toxicology
VL  - 107
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/j.1742-7843.2010.00600.x
DO  - doi:10.1111/j.1742-7843.2010.00600.x
SP  - 162
EP  - 692
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts TPS
JO  - Allergy
JA  - Allergy
VL  - 73
IS  - S105
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.13539
DO  - doi:10.1111/all.13539
SP  - 370
EP  - 702
PY  - 2018
ER  - 

TY  - JOUR
AU  - Gonzalez-Fernandez, Tomas
AU  - Kelly, Daniel J.
AU  - O'Brien, Fergal J.
C7  - 1800038
TI  - Controlled Non-Viral Gene Delivery in Cartilage and Bone Repair: Current Strategies and Future Directions
JO  - Advanced Therapeutics
JA  - Adv. Therap.
VL  - 1
IS  - 7
UR  - https://doi.org/10.1002/adtp.201800038
DO  - doi:10.1002/adtp.201800038
SP  - 1800038
KW  - bones
KW  - cartilage
KW  - gene-activated scaffolds
KW  - non-viral gene delivery
KW  - orthopedic gene therapy
KW  - tissue engineering
PY  - 2018
AB  - Abstract Recent advances in the approval and commercialization of gene therapeutics have fostered the return of gene therapy to center stage. But despite new optimism, no Food and Drug Administration approved product exists for the treatment of orthopedic disorders. Non-viral gene delivery is a promising alternative to recombinant protein administration and viral gene transduction for orthopedic tissue engineering. When applied using appropriately designed systems, it enables temporal control of the overexpression of therapeutic genes, leading to local production of regulatory factors at physiologically relevant levels. Incorporating genetic material into 3D scaffold biomaterials, that is, gene activated scaffolds or hydrogels, presents a particular opportunity to utilize non-viral gene therapy for in situ transfection of host cells and the regeneration of damaged tissues and organs. But controlled non-viral gene delivery for musculoskeletal regeneration depends on a multifactorial design in which the choice of gene delivery method, therapeutic gene, and supportive biomaterial play a central role for the success of this strategy. This paper reviews the different modalities of non-viral gene delivery used for the repair of bone and cartilage, and explores the current challenges and opportunities for the engineering of functional orthopedic tissues using gene activated scaffolds.
ER  - 

TY  - JOUR
TI  - ASBMR 2010 Annual Meeting SA0001–SA0485
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 25
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650251303
DO  - doi:10.1002/jbmr.5650251303
SP  - S136
EP  - S224
PY  - 2010
ER  - 

TY  - JOUR
TI  - Free Communications in Focused Conferences
JO  - Basic & Clinical Pharmacology & Toxicology
VL  - 107
IS  - s1
SN  - 1742-7835
UR  - https://doi.org/10.1111/j.1742-7843.2010.00599.x
DO  - doi:10.1111/j.1742-7843.2010.00599.x
SP  - 112
EP  - 161
PY  - 2010
ER  - 

TY  - JOUR
TI  - Thematic Poster Sessions – Tuesday
JO  - Allergy
VL  - 66
IS  - s94
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2011.02608.x
DO  - doi:10.1111/j.1398-9995.2011.02608.x
SP  - 482
EP  - 642
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Diseases of the Esophagus
JA  - Dis Esophagus
VL  - 27
IS  - S1
SN  - 1120-8694
UR  - https://doi.org/10.1111/dote.12287
DO  - doi:10.1111/dote.12287
SP  - 3A
EP  - 168A
PY  - 2014
ER  - 

TY  - JOUR
TI  - 135th Annual Meeting Poster Session AbstractsMonday, September 13, 2010
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 68
IS  - S14
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.22175
DO  - doi:10.1002/ana.22175
SP  - S4
EP  - S62
PY  - 2010
ER  - 

AU  - Teixeira, F.G.
AU  - Pires, A.
AU  - Serra, S.C.
AU  - Sousa, N.
AU  - Salgado, A.J.
C7  - pp. 222-235
TI  - The evolving concept of mesenchymal stromal cells in regenerative medicine
SN  - 9781118907511
UR  - https://doi.org/10.1002/9781118907474.ch18
DO  - doi:10.1002/9781118907474.ch18
SP  - 222-235
KW  - mesenchymal stromal cells
KW  - mesenchymal stem cells
KW  - secretome
PY  - 2010
AB  - Mesenchymal stromal cells (MSCs), derived from mesenchymal stem cells, have been suggested as possible therapeutic tools for regenerative medicine. This chapter discusses the current understanding of the MSC secretome and its possible applications to regenerative medicine. It focuses particularly on the secretome composition and characterization, as well as its application in graft-versus-host-disease (GVHD) and disorders of the nervous system. Over the last several years it has become evident that some therapeutic effects mediated by MSCs are mainly associated with the secretion of bioactive molecules and vesicles, which constitute their secretome. Allogeneic hematopoietic stem cell transplantation (HSCT) is most commonly used to treat hematological malignancy for which no other potentially curative procedure is available. GVHD remains a major cause of morbidity and mortality in allogeneic HSCT recipients, even when the donor and recipient have a high level of human leukocyte antigen compatibility.
ER  - 

TY  - JOUR
TI  - TSANZ Abstracts—Posters
JO  - Respirology
VL  - 12
IS  - s1
SN  - 9781118907511
UR  - https://doi.org/10.1111/j.1440-1843.2007.001051.x
DO  - doi:10.1111/j.1440-1843.2007.001051.x
SP  - A30
EP  - A78
PY  - 2007
ER  - 

TY  - JOUR
TI  - 2015 ASPHO Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 62
IS  - S2
SN  - 9781118907511
UR  - https://doi.org/10.1002/pbc.25540
DO  - doi:10.1002/pbc.25540
SP  - S21
EP  - S119
PY  - 2015
ER  - 

TY  - JOUR
TI  - Oral Session
JO  - Nephrology
JA  - Nephrology
VL  - 19
IS  - S2
SN  - 9781118907511
UR  - https://doi.org/10.1111/nep.12236_2
DO  - doi:10.1111/nep.12236_2
SP  - 26
EP  - 76
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Clinical Endocrinology
JA  - Clin Endocrinol
VL  - 89
IS  - S1
SN  - 9781118907511
UR  - https://doi.org/10.1111/cen.13727
DO  - doi:10.1111/cen.13727
SP  - 4
EP  - 94
PY  - 2018
ER  - 

TY  - JOUR
TI  - Scandinavian Society for Immunology in Stockholm August 12-15, 2008
JO  - Scandinavian Journal of Immunology
VL  - 68
IS  - 2
SN  - 9781118907511
UR  - https://doi.org/10.1111/j.1365-3083.2008.02124.x
DO  - doi:10.1111/j.1365-3083.2008.02124.x
SP  - 184
EP  - 260
PY  - 2008
ER  - 

TY  - JOUR
TI  - Key Lectures
JO  - Reproduction in Domestic Animals
VL  - 47
IS  - s2
SN  - 9781118907511
UR  - https://doi.org/10.1111/j.1439-0531.2012.01989.x
DO  - doi:10.1111/j.1439-0531.2012.01989.x
SP  - 1
EP  - 63
PY  - 2012
ER  - 

TY  - JOUR
TI  - Poster Session 2: Experimental Hepatocarcinogenesis
JO  - Hepatology
JA  - Hepatology
VL  - 60
IS  - S1
SN  - 9781118907511
UR  - https://doi.org/10.1002/hep.27515
DO  - doi:10.1002/hep.27515
SP  - 634A
EP  - 658A
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts from the XXXVIII Congress of the European Society for Artificial Organs (ESAO 2011) and IV Biennial Congress of the International Federation on Artificial Organs (IFAO 2011)
JO  - Artificial Organs
VL  - 35
IS  - 9
SN  - 9781118907511
UR  - https://doi.org/10.1111/j.1525-1594.2011.01335.x
DO  - doi:10.1111/j.1525-1594.2011.01335.x
SP  - A49
EP  - A141
PY  - 2011
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 9781118907511
UR  - https://doi.org/10.1111/jgh.12363_1
DO  - doi:10.1111/jgh.12363_1
SP  - 1
EP  - 22
PY  - 2013
ER  - 

TY  - JOUR
C7  - 49
TI  - Annual Symposium of the Society for the Study of Inborn Errors of Metabolism
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 34
IS  - S3
SN  - 9781118907511
UR  - https://doi.org/10.1007/s10545-011-9371-z
DO  - doi:10.1007/s10545-011-9371-z
SP  - 49
PY  - 2011
ER  - 
